GlassScriptPhysician profile
Irum Ziauddin
NPI 1386686905
$3,736.56
in general payments reported to CMS, 2019-2025
17 companies · $846 in 2025
The $846 reported for 2025 was more than what 77% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $797 · 2022: $468 · 2023: $835 · 2024: $791 · 2025: $846.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,471.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $507.19 | 2021-2025 | Xarelto, Spravato |
| Novo Nordisk INC | $468.10 | 2023-2025 | Ozempic, Wegovy |
| Alnylam Pharmaceuticals INC. | $365.89 | 2021-2023 | Onpattro |
| Boston Scientific Corporation | $290.71 | 2022-2025 | Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $270.12 | 2022-2025 | Airsupra, Farxiga |
| Inari Medical, INC. | $255.78 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Actelion Pharmaceuticals US, INC. | $249.99 | 2024 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $212.69 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $178.72 | 2023 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $160.54 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.09 | 2021-2023 | Jardiance |
| Scpharmaceuticals INC. | $136.96 | 2023 | |
| Silk Road Medical, INC. | $129.24 | 2022 | |
| Alexion Pharmaceuticals, INC. | $124.88 | 2021 | |
| Sanofi-Aventis U.S. LLC | $122.27 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $94.23 | 2022 | |
| Dynavax Technologies Corporation | $23.16 | 2024 | Heplisav-B |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irum Ziauddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.